Back to search
FDAFDA · Food and drugs·Recall number Z-1512-2013

ADVIA Centaur® iPTH ReadyPack Assay 100 Tests; REF 10492368. For in vitro diagnostic use in the quantitative determination of intact parathyroid hormone (iPTH).

Published June 12, 2013 · Recall initiated: May 14, 2013

Summary

FDA records medical device Class II recall Z-1512-2013, published June 12, 2013 and initiated May 14, 2013. Recalling firm: Siemens Healthcare Diagnostics, Inc; Status: Terminated; Reported quantity: 309 (100 test) kits; Lot: Reagent Lot Number: 056301 and 56302 Kit Lot Number/Exp. Date: 61655301 09 Nov 2011 61950302 09 Nov 2011. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

iPTH Assay- reagent and calibrator lots may have demonstrated higher than anticipated variability

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc
Distributor
Nationwide Distribution.
Lot
Reagent Lot Number: 056301 and 56302 Kit Lot Number/Exp. Date: 61655301 09 Nov 2011 61950302 09 Nov 2011
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ADVIA Centaur® iPTH ReadyPack Assay 100 Tests; REF 10492368. For in vitro diagnostic use in the quantitative determination of intact parathyroid hormone (iPTH). recalled?

Yes. FDA published recall Z-1512-2013 on June 12, 2013. Reported hazard: iPTH Assay- reagent and calibrator lots may have demonstrated higher than anticipated variability

What should I do if I have this product?

Voluntary: Firm initiated · Letter